探索脑静脉血栓症中的血栓组成:第一份病例报告,初步见解和对治疗进展的影响
Ghil Schwarz1, Angelo Cascio Rizzo2, Martina Di Como3
1Department of Neurology and Stroke Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy. ghilschwarz@gmail.com.
概括
脑静脉血栓瘤 (CVT) 的内血管血栓切除术 (EVT) 清除了富含红细胞的血块. 组织学分析显示了中性粒细胞的主导地位,为CVT病理生理学和治疗策略提供了新的见解.
科学领域:
- 神经学 神经学
- 血管医学 血管医学
- 血栓形成研究研究
背景情况:
- 脑静脉血栓塞 (CVT) 可能需要内血管血栓切除术 (EVT) 对于患者的症状恶化尽管抗凝药.
- 在CVT中了解血栓组成对于阐明疾病机制和开发新型治疗方法至关重要.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
701
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
701
Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
Disorders of Hemostasis
918
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
918


